Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS)
CNY 8.37
(1.09%)
CNY 8.37
(1.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 249.26 Million CNY | -5.74% |
| 2022 | 312.16 Million CNY | -7.27% |
| 2021 | 336.64 Million CNY | -11.13% |
| 2020 | 378.82 Million CNY | 11.03% |
| 2019 | 341.19 Million CNY | 41.15% |
| 2018 | 241.72 Million CNY | 141.03% |
| 2017 | 100.28 Million CNY | 13.69% |
| 2016 | 88.2 Million CNY | -9.88% |
| 2015 | 97.88 Million CNY | 3.42% |
| 2014 | 94.64 Million CNY | 32.7% |
| 2013 | 71.32 Million CNY | 6.65% |
| 2012 | 66.87 Million CNY | 15.33% |
| 2011 | 57.98 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 83.42 Million CNY | -16.06% |
| 2024 Q1 | 78.02 Million CNY | 0.5% |
| 2024 Q2 | 81.13 Million CNY | 3.99% |
| 2023 Q3 | 71.22 Million CNY | -8.44% |
| 2023 Q4 | 77.64 Million CNY | 9.01% |
| 2023 FY | 294.24 Million CNY | -5.74% |
| 2023 Q1 | 67.58 Million CNY | -0.67% |
| 2023 Q2 | 77.79 Million CNY | 15.11% |
| 2022 FY | 312.16 Million CNY | -7.27% |
| 2022 Q3 | 81.13 Million CNY | 0.22% |
| 2022 Q4 | 68.04 Million CNY | -16.14% |
| 2022 Q2 | 80.95 Million CNY | -1.31% |
| 2022 Q1 | 82.03 Million CNY | 9.0% |
| 2021 Q2 | 95.1 Million CNY | 14.79% |
| 2021 Q1 | 82.85 Million CNY | -30.23% |
| 2021 Q3 | 83.42 Million CNY | -12.28% |
| 2021 Q4 | 75.25 Million CNY | -9.8% |
| 2021 FY | 336.64 Million CNY | -11.13% |
| 2020 Q1 | 69.14 Million CNY | -32.91% |
| 2020 FY | 378.82 Million CNY | 11.03% |
| 2020 Q3 | 103.46 Million CNY | 18.28% |
| 2020 Q4 | 118.75 Million CNY | 14.78% |
| 2020 Q2 | 87.46 Million CNY | 26.5% |
| 2019 Q1 | 66.51 Million CNY | -12.83% |
| 2019 FY | 341.19 Million CNY | 41.15% |
| 2019 Q4 | 103.05 Million CNY | 23.24% |
| 2019 Q3 | 83.61 Million CNY | -4.98% |
| 2019 Q2 | 88 Million CNY | 32.31% |
| 2018 Q1 | 50.52 Million CNY | 43.75% |
| 2018 Q2 | 50.57 Million CNY | 0.09% |
| 2018 Q4 | 76.3 Million CNY | 18.63% |
| 2018 Q3 | 64.32 Million CNY | 27.19% |
| 2018 FY | 241.72 Million CNY | 141.03% |
| 2017 Q4 | 35.14 Million CNY | 40.83% |
| 2017 Q1 | 20.23 Million CNY | -31.42% |
| 2017 Q2 | 19.94 Million CNY | -1.46% |
| 2017 Q3 | 24.95 Million CNY | 25.15% |
| 2017 FY | 100.28 Million CNY | 13.69% |
| 2016 Q2 | 20.65 Million CNY | -12.12% |
| 2016 Q4 | 29.5 Million CNY | 102.89% |
| 2016 Q3 | 14.54 Million CNY | -29.58% |
| 2016 Q1 | 23.5 Million CNY | 0.0% |
| 2016 FY | 88.2 Million CNY | -9.88% |
| 2015 FY | 97.88 Million CNY | 3.42% |
| 2014 Q2 | 19.49 Million CNY | 0.0% |
| 2014 FY | 94.64 Million CNY | 32.7% |
| 2014 Q1 | 19.49 Million CNY | 0.0% |
| 2013 FY | 71.32 Million CNY | 6.65% |
| 2012 FY | 66.87 Million CNY | 15.33% |
| 2011 FY | 57.98 Million CNY | 0.0% |